Pursuing new tools and capabilities in sample logistics, storage, and data analysis.
At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Insights identify opportunities to optimize sponsor, CRO, and site collaborations.
Key considerations in deploying fit-for-purpose digital health technologies in drug development.
Good scientific principles and practices are essential for maintaining quality data that patients can benefit from.
The challenges, opportunities, and strategic outlook for oncology research centers.
Increased outreach is necessary to combat poor recruitment and large focus on patients near study centers.
Understanding the role of social determinants on clinical trial participation and trust.
eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.
COVID-19 not only advanced scientific boundaries, but also transformed research methodologies and accelerated adaptive clinical trial design.
How partnering with a CRO that has experience in both dermatology and innovative trial approaches can help sponsors differentiate their studies and facilitate recruitment.
Optimizing feasibility through increased data collection.
Industry provides endless methods in crafting solutions for patients.
Explore the pivotal role of Next-Generation Sequencing (NGS) panel customization in driving advancements in oncology research.
Recent study results highlight need for new metrics in ECOG scoring to mitigate variability.
A data-fueled framework for sponsors and CROs in navigating this shifting terrain.
New requirements must be put in place to ensure data quality and integrity.
The role of the clinical research associate may be key in addressing challenges around the adoption of digital tools.
How one CRO in India quickly implemented processes and technology to mitigate risk
Many companies have implemented new technologies and are adopting clinical trial models that are more patient-centric.
Monday, October 25, 2021 at 10am EDT Attend this webinar to hear about CGP, the latest in onco-innovation for genomic biomarker testing and uncover the role that Illumina and Q2 Solutions are playing in evolving the CGP testing landscape to deliver a localized testing model to support oncology precision medicine clinical trials in Europe. Lastly, the webinar will reveal the updated roadmap of Q2 Solutions’ Edinburgh Genomics laboratory.
Push for accurate data collection during pandemic led by increased focus on patient engagement.
Study evaluates the use of AI-supported medical coding module.
To have a successful integration of data from across clinical systems, a strong understanding of the data is a critical.
Oncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.
Industry must work closely with patients to advance the use of decentralized technology.
Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed the cycle of reliance on incremental gains.